Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Frey

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Currents in Pharmacy Teaching & Learning|April 11, 2020
Structure activity relationship (SAR) maps: A student-friendly tool to teach medicinal chemistry in integrated pharmacotherapy coursesKathleen M Frey
Future Microbiology|October 31, 2015
Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variantsKathleen M Frey
Journal of Pain & Palliative Care Pharmacotherapy|December 27, 2025
The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for PracticeShannon Moriarty, Anna Dushenkov, Kathleen M Frey
AAPS Pharmscitech|September 5, 2020
Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release BehaviorsIoannis Serris, Panagiotis Serris, Kathleen M Frey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
Predicting resistance mutations using protein design algorithmsKathleen M Frey, Ivelin Georgiev, Bruce R Donald, et al.
Current HIV Research|June 5, 2020
Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase InhibitorsTasnim Tabassum, Syeda M Azeem, Alecia N Muwonge, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistanceKathleen M Frey, Kishore Viswanathan, Dennis L Wright, et al.
The Annals of Pharmacotherapy|February 3, 2021
Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of AcneJulie Kalabalik-Hoganson, Kathleen M Frey, Ayse Elif Ozdener-Poyraz, et al.
Journal of Structural Biology|December 23, 2009
Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductaseKathleen M Frey, Michael N Lombardo, Dennis L Wright, et al.
Biochemistry|March 28, 2009
The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitorsJennifer M Beierlein, Lalit Deshmukh, Kathleen M Frey, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Currents in Pharmacy Teaching & Learning|April 11, 2020
Structure activity relationship (SAR) maps: A student-friendly tool to teach medicinal chemistry in integrated pharmacotherapy coursesKathleen M Frey
Future Microbiology|October 31, 2015
Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variantsKathleen M Frey
Journal of Pain & Palliative Care Pharmacotherapy|December 27, 2025
The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for PracticeShannon Moriarty, Anna Dushenkov, Kathleen M Frey
AAPS Pharmscitech|September 5, 2020
Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release BehaviorsIoannis Serris, Panagiotis Serris, Kathleen M Frey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
Predicting resistance mutations using protein design algorithmsKathleen M Frey, Ivelin Georgiev, Bruce R Donald, et al.
Current HIV Research|June 5, 2020
Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase InhibitorsTasnim Tabassum, Syeda M Azeem, Alecia N Muwonge, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistanceKathleen M Frey, Kishore Viswanathan, Dennis L Wright, et al.
The Annals of Pharmacotherapy|February 3, 2021
Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of AcneJulie Kalabalik-Hoganson, Kathleen M Frey, Ayse Elif Ozdener-Poyraz, et al.
Journal of Structural Biology|December 23, 2009
Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductaseKathleen M Frey, Michael N Lombardo, Dennis L Wright, et al.
Biochemistry|March 28, 2009
The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitorsJennifer M Beierlein, Lalit Deshmukh, Kathleen M Frey, et al.
Pageof 4